Andrew Fish is the President & CEO of the Medical Device Innovation Consortium (MDIC). As a unique public-private partnership, MDIC’s members include both medical technology manufacturers and key government agencies, including the U.S. Food and Drug Administration and the Centers for Medicare and Medicaid Services. MDIC addresses complex challenges in medical technology regulatory science – the scientific and technical disciplines that drive medical technology research, development, and manufacturing and inform decision making for regulators, payers, health care providers and patients.
Mr. Fish has an extensive record of solving high-stakes challenges at the complex intersections of regulated business, health care, science, technology, law, media, and politics. Prior to joining MDIC in 2022, Mr. Fish held various roles at AdvaMed, the Advanced Medical Technology Association, including Chief Strategy Officer, the first Executive Director of the AdvaMed Center for Digital Health, Head of Sector Initiatives, and the first Executive Director of AdvaMedDx, AdvaMed’s in vitro diagnostics division. In his leadership roles with AdvaMed, Mr. Fish oversaw the association’s global and domestic policy and advocacy agenda and launched and led specific organizational and issue initiatives, including AdvaMed’ s Diabetes Sector, Radiation Therapy Sector, Cancer Forum, and the AdvaMed Data Stewardship & Privacy initiative.
Mr. Fish previously served as Senior Vice President of Legal and Government Affairs, General Counsel, and Secretary for the Consumer Healthcare Products Association, and prior to that position led the American Cancer Society’s federal lobbying team as the Senior Director of Federal Government Relations. Earlier in Mr. Fish’s career, he served in the Senate-confirmed post of Assistant Secretary of Agriculture for Congressional and Intergovernmental Affairs after working as deputy chief counsel for the U.S. Senate Agriculture Committee. Mr. Fish holds a BA from Yale University and a JD from Stanford Law School.